Pfizer, BioNTech Seek to Revoke CureVac's Patent Infringement Claims
Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their COVID-19 vaccine, based on mRNA technology, does not infringe on CureVac's European patents.
Reuters Health Information
source https://www.medscape.com/viewarticle/980172?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/980172?src=rss
Comments
Post a Comment